Regarding psychedelics, a new industry has emerged within the country: ketamine clinics. Now a normalized way to treat depression-related illnesses, ketamine, and Spravato, as treatments, have fast become available nationwide with the number of new clinics skyrocketing.
Ketamine And Spravato Prescribed In Ketamine Clinics
NBC reports, “Ketamine is a hallucinogen approved by the Food and Drug Administration as an anesthetic for decades. Over the last few years, growing research has found that the drug also works for treatment-resistant depression in some people, which led the FDA to approve a version called esketamine, or Spravato, in 2019.”
Spravato, a nasal spray medication not explicitly approved for mental health conditions but approved by the Food and Drug Administration, is an inhaled version of ketamine. It is administered in a doctor’s office. Patients who have tried common treatments, but have failed to see results for their depression, are approved to use Spravato, or injection or infusion variants to combat their mental health problems.
Treatments Are Becoming Normalized, Pushing The Rise Of Clinics
Working to combat treatment-resistant depression in some individuals, both ketamine and Spravato treatments and ketamine infusion therapy, costing from $400 to $800 a session, are said to benefit individuals with mental health conditions.
While it is still unclear how both alternative treatments work within the brain, many believe both boost feel-good chemicals, reduce inflammation and effectively form new neural pathways. The pathways help the individual create new and positive behaviors and habits. The spiritual, psychedelic experiences help individuals grow spiritually and boost their mood.
Ketamine Clinic Numbers In Focus
According to online sources, “From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. “ This number is indeed higher with news that many centers are rising, for example, the Ketamine Wellness Centers.
Considering that Ketamine Wellness Centers currently has 13 clinics in nine states, with plans for more by the end of the year, and other clinics set to grow in much the same manner, the total number of clinics across the country will boom.
According to Medscape, “The number of ketamine clinics in the United States has grown exponentially and is estimated to be anywhere from 500 to 750.”
For now, as stated by the FDA, “Because of the risk of serious adverse outcomes resulting from sedation and dissociation caused by Spravato administration, and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system, under a Risk Evaluation and Mitigation Strategy (REMS).”
Guidance For Clinics In A Dangerous Industry
As the number of clinics grows, some doctors are concerned that it’s an unregulated industry filled with potential danger. To avoid the pitfalls and problems raised by the medical world and the public world, it is of the utmost importance for doctors and clinics prescribing Spravato and Ketamine treatments to be equipped to respond to patients during treatments. Doctors and clinics are also advised to offer the treatment with full supervision.
While the clinics aren’t regulated federally, they are subject to the same state laws as other outpatient medical clinics and must keep this in mind. Guidelines according to federal regulations must also be kept in mind to ensure safety for all and avoid potential risks and dangers.
Subject to the same state laws as other outpatient medical clinics, and the industry in a prime position for regulation, it is hoped that these clinics will operate in such a way that doom does not fall in such a way that the industry falls victim to concerns and patients ultimately suffer.
Guidance For Patients
Regarding the medication, patients are advised to read the Spravato labeling, which does caution them that they are at risk for sedation and may experience difficulty with attention, judgment, and thinking. Patients are advised against abuse and misuse, and should they experience suicidal thoughts and behaviors after administering the drug, they must contact their doctor immediately. However, ultimately, patients must be monitored by a doctor for at least two hours after taking their Spravato dose.
The FDA explains that a Patient Enrollment Form needs to be signed and, with that, the acknowledgment from the patient that they understand the need to make arrangements to get home after treatment. The form also states that the patient must neither lift nor operate heavy machinery. Additionally, as explained by the FDA, treatments must always be dispensed with a patient Medication Guide that clearly outlines uses and risks.
More story updates to follow as more news becomes available.
Enjoyed that first hit? Come chill with us every week at the Friday Sesh for a freshly packed bowl of the week’s best cannabis news!